Shanghai Fosun Pharmaceutical Group Co Ltd 2023 SR
In 2023, Fosun Pharma advanced its 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), focusing on unmet clinical needs. Key achievements include the inclusion of several innovative drugs in China's National Medical Insurance Drug Catalogue and the domestic production of the Da Vinci Xi Surgical Robot. The Group expanded its global reach, particularly in Africa, where its anti-malarial drug Artesun has treated over 68 million patients. Environmentally, Fosun Pharma established a Carbon Neutrality Committee and met its 2023 targets for carbon emission and energy consumption intensity. Socially, the 'Fosun Care 121' fund supported rural health and women's cancer screening. The Group also maintained high standards in quality management and pharmacovigilance, ensuring product safety and accessibility.
Company: Shanghai Fosun Pharmaceutical Group Co Ltd
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 137
Shanghai Fosun Pharmaceutical Group Co Ltd
ESG And Sustainability Report
In 2023, Fosun Pharma advanced its 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), focusing on unmet clinical needs. Key achievements include the inclusion of several innovative drugs in China's National Medical Insurance Drug Catalogue and the domestic production of the Da Vinci Xi Surgical Robot. The Group expanded its global reach, particularly in Africa, where its anti-malarial drug Artesun has treated over 68 million patients. Environmentally, Fosun Pharma established a Carbon Neutrality Committee and met its 2023 targets for carbon emission and energy consumption intensity. Socially, the 'Fosun Care 121' fund supported rural health and women's cancer screening. The Group also maintained high standards in quality management and pharmacovigilance, ensuring product safety and accessibility.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees